Stockscreener 앱 받기
0.7967
0.86%
-0.0069
전일 마감가:
$0.8036
열려 있는:
$0.828
하루 거래량:
777.44K
Relative Volume:
1.21
시가총액:
$41.29M
수익:
-
순이익/손실:
$-81.22M
주가수익비율:
-0.2692
EPS:
-2.96
순현금흐름:
$-74.41M
1주 성능:
+0.85%
1개월 성능:
-5.46%
6개월 성능:
+4.05%
1년 성능:
-37.27%
1일 변동 폭
$0.7714
$0.828
1주일 범위
$0.7714
$0.8989
52주 변동 폭
$0.615
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
명칭
Xilio Therapeutics Inc
전화
617-833-1027
주소
828 WINTER STREET, WALTHAM
XLO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.7967 | 41.65M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | Leerink Partners | Outperform |
| 2022-12-21 | 개시 | Chardan Capital Markets | Buy |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
| 2021-11-16 | 개시 | Cowen | Outperform |
| 2021-11-16 | 개시 | Guggenheim | Buy |
| 2021-11-16 | 개시 | Morgan Stanley | Overweight |
| 2021-11-16 | 개시 | Raymond James | Outperform |
모두보기
Xilio Therapeutics Inc 주식(XLO)의 최신 뉴스
How Xilio Therapeutics Inc. stock performs in high volatility marketsEarnings Risk Report & Fast Entry High Yield Stock Tips - newser.com
Why Xilio Therapeutics Inc. stock remains on watchlistsStop Loss & Daily Stock Momentum Reports - newser.com
Volume spikes in Xilio Therapeutics Inc. stock – what they meanTreasury Yields & Real-Time Volume Triggers - newser.com
Why analysts remain bullish on Xilio Therapeutics Inc. stockJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com
Tools to assess Xilio Therapeutics Inc.’s risk profile2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Xilio to present vilastobart phase 2 data at SITC annual meeting - Investing.com Australia
How Xilio Therapeutics Inc. stock compares to market leadersJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
Best data tools to analyze Xilio Therapeutics Inc. stockMarket Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com
What the charts say about Xilio Therapeutics Inc. todaySwing Trade & Technical Pattern Based Buy Signals - newser.com
Volatility clustering patterns for Xilio Therapeutics Inc.July 2025 Catalysts & Smart Investment Allocation Insights - newser.com
What Fibonacci levels say about Xilio Therapeutics Inc. reboundTake Profit & Daily Profit Focused Stock Screening - newser.com
Is Xilio Therapeutics Inc. stock safe for conservative investorsWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com
Is Xilio Therapeutics Inc. stock a buy before product launchesQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com
How geopolitical tensions affect Xilio Therapeutics Inc. stockInsider Buying & Technical Entry and Exit Tips - newser.com
Using data models to predict Xilio Therapeutics Inc. stock movement2025 Fundamental Recap & Weekly High Momentum Picks - newser.com
Why Xilio Therapeutics Inc. stock is in analyst buy zone2025 Macro Impact & Short-Term High Return Strategies - newser.com
What makes Xilio Therapeutics Inc. stock attractive to growth funds2025 Price Targets & Community Consensus Picks - newser.com
Can Xilio Therapeutics Inc. stock deliver sustainable ROE2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Xilio to present vilastobart phase 2 data at SITC annual meeting By Investing.com - Investing.com South Africa
Xilio (Nasdaq: XLO) late-breaking Phase 2 vilastobart poster at SITC on MSS mCRC, high pTMB - Stock Titan
What machine learning models say about Xilio Therapeutics Inc.Portfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
Published on: 2025-10-30 02:53:37 - newser.com
Will Xilio Therapeutics Inc. stock remain a Wall Street favoriteBuy Signal & Safe Capital Preservation Plans - newser.com
Published on: 2025-10-28 23:16:50 - newser.com
Xilio Therapeutics Inc (XLO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):